Evidence map›Paper›PMID 25552739›Full record

ArticleThe European respiratory journal2015

Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.

Timo Weiss, Nicolas Schönfeld, Ralf Otto-Knapp, Lena Bös, Gudrun Bettermann, Harald Mauch, Torsten Thomas Bauer, Holger Rüssmann

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The European respiratory journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Timo WeissKlinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany tiweiss@t-online.de.
Nicolas SchönfeldKlinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany.
Ralf Otto-KnappKlinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK), Berlin, Germany.
Lena BösDeutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK), Berlin, Germany.
Gudrun BettermannInstitut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin, Germany.
Harald MauchInstitut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin, Germany.
Torsten Thomas BauerKlinik für Pneumologie, Lungenklinik Heckeshorn, HELIOS Klinikum Emil von Behring, Berlin, Germany Deutsches Zentralkomitee zur Bekämpfung der Tuberkulose (DZK), Berlin, Germany.
Holger RüssmannInstitut für Mikrobiologie, Immunologie und Laboratoriumsmedizin, HELIOS Klinikum Emil von Behring, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetamidesAntitubercular AgentsExtensively Drug-Resistant TuberculosisFemaleHumansMaleOxazolidinonesTuberculosis, Multidrug-ResistantAcetamidesAntitubercular AgentsOxazolidinones

Identifiers

PMID25552739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.